Search Results - "Doxorubicin/administration"
-
1
Authors:
Source: Surg Endosc
Subject Terms: Aerosols, Nebulizers and Vaporizers, Urinary Bladder, Antineoplastic Agents, Equipment Design, Article, Nebulizers and Vaporizers [MeSH], Aerosols [MeSH], Cisplatin/administration, Antineoplastic Agents/administration, Peritoneum, Nebuliser, Animals [MeSH], Drug Delivery Systems/instrumentation [MeSH], Antineoplastic Agents/pharmacokinetics [MeSH], Urinary Bladder [MeSH], Tissue Distribution [MeSH], Intraperitoneal drug delivery, Peritoneal metastasis, Doxorubicin/administration, Equipment Design [MeSH], Particle Size [MeSH], Cattle [MeSH], Doxorubicin/pharmacokinetics [MeSH], Cisplatin/pharmacokinetics [MeSH], Administration, Inhalation [MeSH], Pressurised intraperitoneal aerosol chemotherapy—PIPAC, 03 medical and health sciences, Drug Delivery Systems, 0302 clinical medicine, Doxorubicin, Administration, Inhalation, Animals, Cattle, Tissue Distribution, Cisplatin, Particle Size
-
2
Authors: et al.
Source: Arch Gynecol Obstet
Subject Terms: Ribonuclease III, Cryopreservation, Adolescent, Uterine Cervical Neoplasms, Fertility Preservation, Sarcoma, Cervix Uteri, Gynecologic Oncology, DEAD-box RNA Helicases, 03 medical and health sciences, 0302 clinical medicine, Doxorubicin, Mutation, Ifosfamide/administration, Adolescent [MeSH], Ribonuclease III/genetics [MeSH], Mutation [MeSH], Sarcoma/diagnostic imaging [MeSH], Uterine Cervical Neoplasms/diagnostic imaging [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Dicer-1 sarcoma, Fertility [MeSH], Uterine Cervical Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Tomography, X-Ray Computed [MeSH], Magnetic Resonance Imaging [MeSH], Cervical sarcoma, Doxorubicin/administration, Sarcoma/drug therapy [MeSH], Fertility preservation, Fertility sparing, Humans, Female, Ifosfamide
-
3
Authors: et al.
Source: BMJ Case Reports, 18 (7), e265774 (2025-07-28)
Subject Terms: Dermatology, Haematology (incl blood transfusion), Malignant disease and immunosuppression, Renal transplantation, Prednisone, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Age of Onset, Immunosuppression Therapy, In Situ Hybridization, Positron Emission Tomography Computed Tomography, Diagnosis, Differential, Humans, Female, Aged, Skin/virology, Prednisone/administration & dosage, Rituximab/administration & dosage, Cyclophosphamide/administration & dosage, Doxorubicin/administration & dosage, Vincristine/administration & dosage, Pigmentation, Lymphoproliferative Disorders/virology, Epstein-Barr Virus Infections/virology, Herpesvirus 4, Human/isolation & purification, Kidney Transplantation/adverse effects, Antineoplastic Combined Chemotherapy Protocols, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Kidney Transplantation, Lymphoproliferative Disorders, Skin Neoplasms, Medicine (all), Human health sciences, Sciences de la santé humaine, Dermatologie
Relation: https://syndication.highwire.org/content/doi/10.1136/bcr-2025-265774; urn:issn:1757-790X
Access URL: https://orbi.uliege.be/handle/2268/335735
-
4
Authors: et al.
Source: Ann Hematol
Subject Terms: Male, Adult, Aged, 80 and over, ddc:610, Research, Middle Aged, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Vincristine, Doxorubicin, Germany, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Humans, Prednisone, Female, Lymphoma, Large B-Cell, Diffuse, Prospective Studies, Rituximab, Cyclophosphamide, Aged, 80 and over [MeSH], Aged [MeSH], Cyclophosphamide/therapeutic use [MeSH], DLBCL, Rituximab/administration, Cyclophosphamide/administration, Rituximab/therapeutic use [MeSH], Male [MeSH], Real world, Quality of Life [MeSH], Doxorubicin/administration, Prednisone/therapeutic use [MeSH], Biosimilar, Vincristine/administration, Female [MeSH], Follow-Up Studies [MeSH], Lymphoma, Large B-Cell, Diffuse/drug therapy [MeSH], Adult [MeSH], R-CHOP, Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Prednisone/administration, Quality of life, Germany [MeSH], Vincristine/therapeutic use [MeSH], Doxorubicin/therapeutic use [MeSH], Aged, Follow-Up Studies
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38900302
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-1135713
https://opus.bibliothek.uni-augsburg.de/opus4/files/113571/s00277-024-05850-5.pdf
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/113571
https://doi.org/10.1007/s00277-024-05850-5
https://repository.publisso.de/resource/frl:6517828
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-391620
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39162
https://doi.org/10.1007/s00277-024-05850-5
https://opus.bibliothek.uni-wuerzburg.de/files/39162/00277_2024_Article_5850.pdf -
5
Authors: et al.
Source: Cancer Chemother Pharmacol
Mc Laughlin, Anna M; Hess, Dagmar; Michelet, Robin; Colombo, Ilaria; Haefliger, Simon; Bastian, Sara; Rabaglio, Manuela; Schwitter, Michael; Fischer, Stefanie; Eckhardt, Katrin; Hayoz, Stefanie; Kopp, Christoph; Klose, Marian; Sessa, Cristiana; Stathis, Anastasios; Halbherr, Stefan; Huisinga, Wilhelm; Joerger, Markus; Kloft, Charlotte (2024). Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial. Cancer chemotherapy and pharmacology, 94(3), pp. 349-360. Springer 10.1007/s00280-024-04679-z <http://dx.doi.org/10.1007/s00280-024-04679-z>Subject Terms: Male, Adult, Antibiotics, Antineoplastic, Dose-Response Relationship, Drug, 610 Medicine & health, Middle Aged, Models, Biological, Polyethylene Glycols, 3. Good health, Pharmacometrics, Doxorubicin, Neoplasms, Area Under Curve, Liposomes, Humans, Nanoparticles, Original Article, Female, Pharmacokinetics, Half-Life [MeSH], Area Under Curve [MeSH], Antibiotics, Antineoplastic/pharmacokinetics [MeSH], Aged [MeSH], Models, Biological [MeSH], Male [MeSH], Doxorubicin/administration, Nonlinear mixed-effects model, Polyethylene Glycols/pharmacokinetics [MeSH], Doxorubicin/pharmacokinetics [MeSH], Doxorubicin/analogs, Dose-Response Relationship, Drug [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Antibiotics, Antineoplastic/administration, Neoplasms/drug therapy [MeSH], Polyethylene Glycols/administration, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik, Aged, Half-Life
File Description: application/pdf
-
6
Authors: et al.
Source: Sci Rep
Scientific Reports, Vol 15, Iss 1, Pp 1-16 (2025)Subject Terms: Dilated/drug therapy, Adipose Tissue/metabolism, Male, Cardiomyopathy, Dilated, Cardiomyopathy, Myocardium/metabolism, Science, Stromal Cells/metabolism, Wistar, Stem cells, Cell therapy, Article, Dilated cardiomyopathy (DCM), Animals, Rats, Wistar, Secretome, Pericardium/drug effects, Animal, Myocardium, Doxorubicin/administration & dosage, Hydrogels, Extracellular Matrix/metabolism, Extracellular matrix, Hydrogels/chemistry, Fibrosis, Rats, Extracellular Matrix, Disease Models, Animal, Adipose Tissue, Doxorubicin, Disease Models, Medicine, Stromal Cells, Pericardium
-
7
Authors: et al.
Source: Eur Radiol Exp
European Radiology Experimental, Vol 8, Iss 1, Pp 1-12 (2024)Subject Terms: Male, Adult, Antibiotics, Antineoplastic, Lung Neoplasms, Medizin, Female [MeSH], Aged [MeSH], Lung Neoplasms/therapy [MeSH], Adult [MeSH], Sarcoma, Humans [MeSH], Perfusion, Degradable starch microspheres, Chemoembolization, Therapeutic/methods [MeSH], Middle Aged [MeSH], Antibiotics, Antineoplastic/administration, Lung, Embolization (therapeutic), Original Article, Microspheres [MeSH], Male [MeSH], Sarcoma/therapy [MeSH], Doxorubicin/administration, Sarcoma/drug therapy [MeSH], Starch [MeSH], Lung [MeSH], R895-920, Starch, Middle Aged, Microspheres, Medical physics. Medical radiology. Nuclear medicine, 03 medical and health sciences, 0302 clinical medicine, Doxorubicin, Humans, Female, Chemoembolization, Therapeutic, Aged
Access URL: https://pubmed.ncbi.nlm.nih.gov/39636562
https://doaj.org/article/7c10f7004cdb48e0b06cddb12706ab5c
https://repository.publisso.de/resource/frl:6518270
https://www.ncbi.nlm.nih.gov/pubmed/39636562
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85211136021
https://doi.org/10.1186/s41747-024-00532-3 -
8
Authors: et al.
Source: ECHELON-1 Study Group 2022, 'Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma', The New England Journal of Medicine, vol. 387, no. 4, pp. 310-320. https://doi.org/10.1056/NEJMoa2206125
Subject Terms: Antineoplastic Agents, Immunological/adverse effects, Vinblastine/administration & dosage, Antineoplastic Agents, Vinblastine, Disease-Free Survival, Bleomycin, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immunological/adverse effects, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Humans, Bleomycin/administration & dosage, Hodgkin Disease/drug therapy, Neoplasm Staging, Brentuximab Vedotin, Brentuximab Vedotin/administration & dosage, Manchester Cancer Research Centre, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Dacarbazine/administration & dosage, Doxorubicin/administration & dosage, Hodgkin Disease, Survival Analysis, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, 3. Good health, Dacarbazine, Immunological, Treatment Outcome, Doxorubicin, Follow-Up Studies
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/35830649
-
9
Authors: et al.
Source: J Cancer Res Clin Oncol
Subject Terms: Adult, Aged, 80 and over, Male, 0301 basic medicine, Survivin, Imidazoles, Liposarcoma, Middle Aged, Prognosis, Aged, 80 and over [MeSH], Aged [MeSH], Survivin/antagonists, Naphthoquinones/administration, Tumor Cells, Cultured [MeSH], Etoposide/administration, Male [MeSH], Doxorubicin/administration, Targeted therapy, Liposarcoma/drug therapy [MeSH], Liposarcoma/classification [MeSH], Liposarcoma/pathology [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Apoptosis, Middle Aged [MeSH], Gene Expression Regulation, Neoplastic/drug effects [MeSH], Survival Rate [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Prognosis [MeSH], Liposarcoma/metabolism [MeSH], Inhibitor of apoptosis protein, Imidazoles/administration, Gene Expression Regulation, Neoplastic, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Doxorubicin, Antineoplastic Combined Chemotherapy Protocols, Tumor Cells, Cultured, Humans, Female, Aged, Etoposide, Follow-Up Studies, Naphthoquinones, Retrospective Studies
-
10
Authors: et al.
Contributors: et al.
Source: Ferrari, A, van Noesel, M M, Brennan, B, Zanetti, I, Corradini, N, Casanova, M, Berlanga, P, Merks, J H M, Alaggio, R, Schifflers, S, Ramirez-Villar, G L, Giraudo, C, Burrieza, G G, Safwat, A, Bisogno, G, De Salvo, G L & Orbach, D 2021, 'Paediatric non-rhabdomyosarcoma soft tissue sarcomas : the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)', The Lancet Child & Adolecent Health, vol. 5, no. 8, pp. 546-558. https://doi.org/10.1016/S2352-4642(21)00159-0
Subject Terms: Soft Tissue Neoplasms/drug therapy, Male, 0301 basic medicine, Adolescent, Sarcoma/drug therapy, Sarcoma, Synovial/drug therapy, Soft Tissue Neoplasms, Disease-Free Survival, Sarcoma, Synovial, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Developmental and Educational Psychology, Journal Article, Humans, Pediatrics, Perinatology, and Child Health, Ifosfamide, Prospective Studies, Child, Neoplasm Staging, Research Support, Non-U.S. Gov't, Doxorubicin/administration & dosage, paediatric non-rhabdomiosarcoma chemotherapy, Sarcoma, Chemoradiotherapy, Adjuvant, Ifosfamide/administration & dosage, Clinical Trial, 3. Good health, Europe, Doxorubicin, Practice Guidelines as Topic, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Practice Guidelines as Topic/standards
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/34214481
https://pubmed.ncbi.nlm.nih.gov/34214481/
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00159-0/fulltext
https://www.sciencedirect.com/science/article/abs/pii/S2352464221001590
https://europepmc.org/article/MED/34214481
https://dspace.library.uu.nl/handle/1874/446983
https://hdl.handle.net/11573/1704305
https://doi.org/10.1016/S2352-4642(21)00159-0
http://www.scopus.com/inward/record.url?scp=85110597122&partnerID=8YFLogxK
https://doi.org/10.1016/S2352-4642(21)00159-0
https://pure.au.dk/portal/en/publications/7f1070ca-567f-4ea8-80b9-aafc7d5cdec9 -
11
Authors: et al.
Source: Blood
Blood, 137 (20Subject Terms: Male, Diffuse/drug therapy, Lymphoma, DNA Repair, Humanized/therapeutic use, Neoplasm/biosynthesis, Cyclophosphamide/administration & dosage, Prednisone/administration & dosage, Neoplasm Proteins/genetics, Immunologie, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Vincristine/administration & dosage, Gene Regulatory Networks, Prospective Studies, Chronic, Aged, 80 and over, Leukemia, Neoplastic/genetics, Syndrome, Sciences bio-médicales et agricoles, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Combined Modality Therapy, Lymphocytic, 3. Good health, Gene Expression Regulation, Neoplastic, Disease Progression, Female, Lymphoma, Large B-Cell, Diffuse, Biochimie, 106013 Genetics, Clone Cells/pathology, Antibodies, Monoclonal, Humanized, Antibodies, Clonal Evolution, Large B-Cell, Humans, 106013 Genetik, Cyclophosphamide, Aged, Whole Genome Sequencing, Base Sequence, Doxorubicin/administration & dosage, Leukemia, Lymphocytic, Chronic, B-Cell, Clone Cells, Gene Expression Regulation, Genes, Clonal Evolution/genetics, Doxorubicin, Mutation, Neoplasm, RNA, Biologie cellulaire, B-Cell/genetics, Transcriptome, Hématologie, Genes, Neoplasm
File Description: 2 full-text file(s): application/pdf; application/pdf; 2 full-text file(s): application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Access URL: https://ashpublications.org/blood/article-pdf/137/20/2800/1807536/bloodbld2020005650.pdf
https://pubmed.ncbi.nlm.nih.gov/33206936
https://ucrisportal.univie.ac.at/de/publications/406d7869-f4ee-46c7-8d76-a01ef14da7d4
https://doi.org/10.1182/blood.2020005650
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163497
https://www.ncbi.nlm.nih.gov/pubmed/33206936
https://europepmc.org/article/PMC/PMC8163497
https://lup.lub.lu.se/record/fb917ef9-82a4-4ca2-a8b0-2bf232ab2865
https://pubmed.ncbi.nlm.nih.gov/33206936/
https://portal.research.lu.se/en/publications/genomic-and-transcriptomic-correlates-of-richters-transformation-
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/321418
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/326877 -
12
Authors: et al.
Contributors: et al.
Source: Ann Hematol
Subject Terms: Male, 610 Medizin, Kaplan-Meier Estimate, 03 medical and health sciences, 0302 clinical medicine, 610 Medical sciences, Antineoplastic Combined Chemotherapy Protocols, Humans, Anthracyclines, 10. No inequality, Cyclophosphamide, Aged, Aged, 80 and over, ddc:610, Age Factors [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Aggressive lymphoma, Progression-Free Survival [MeSH], Rituximab/administration, Cyclophosphamide/administration, Original Article, Male [MeSH], Doxorubicin/administration, Geriatric patients, Combined Modality Therapy [MeSH], Treatment, Lymphoma, Large B-Cell, Diffuse/radiotherapy [MeSH], Radiotherapy, Adjuvant [MeSH], Vincristine/administration, Anthracyclines/administration, Female [MeSH], Lymphoma, Large B-Cell, Diffuse/drug therapy [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Lymphoma, Large B-Cell, Diffuse/epidemiology [MeSH], Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Prednisone/administration, Prognosis [MeSH], Lymphoma, Large B-Cell, Diffuse/mortality [MeSH], Age Factors, Prognosis, Combined Modality Therapy, Progression-Free Survival, 3. Good health, Treatment Outcome, Doxorubicin, Vincristine, Prednisone, Female, Radiotherapy, Adjuvant, Lymphoma, Large B-Cell, Diffuse, Rituximab
Access URL: https://link.springer.com/content/pdf/10.1007/s00277-021-04461-8.pdf
https://pubmed.ncbi.nlm.nih.gov/33634349
https://europepmc.org/article/PMC/PMC7960616
https://link.springer.com/content/pdf/10.1007/s00277-021-04461-8.pdf
https://www.scilit.net/article/de6c3d353b302183ddfc22f07783f793?action=show-references
https://pubmed.ncbi.nlm.nih.gov/33634349/
https://paperity.org/p/261027685/cure-rate-in-the-elderly-patients-with-diffuse-large-b-cell-lymphoma-deteriorates-after
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960616
https://repository.publisso.de/resource/frl:6447851 -
13
Authors: et al.
Contributors: et al.
Source: Ann Hematol
Subject Terms: Aged, 80 and over, Male, Lymphoma, B-Cell, Dose-Response Relationship, Drug, Age Factors, Kaplan-Meier Estimate, Antibiotic Prophylaxis, Middle Aged, Age Factors [MeSH], Aged, 80 and over [MeSH], Lymphoma, B-Cell/drug therapy [MeSH], Aged [MeSH], Aggressive lymphoma, Prednisone/adverse effects [MeSH], Multicenter Studies as Topic/statistics, Progression-Free Survival [MeSH], Clinical Trials, Phase II as Topic/statistics, Cyclophosphamide/adverse effects [MeSH], Diffuse large cell lymphoma, Feasibility Studies [MeSH], Rituximab/administration, Cyclophosphamide/administration, Original Article, Clinical Trials, Phase III as Topic/statistics, Male [MeSH], Rituximab/adverse effects [MeSH], Doxorubicin/administration, Randomized Controlled Trials as Topic/statistics, Elderly patients, Vincristine/administration, Dose-Response Relationship, Drug [MeSH], Antibiotic Prophylaxis [MeSH], Female [MeSH], Doxorubicin/adverse effects [MeSH], Infections, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Lymphoma, B-Cell/mortality [MeSH], Treatment-related mortality, Antineoplastic Combined Chemotherapy Protocols/administration, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Prednisone/administration, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Vincristine/adverse effects [MeSH], Progression-Free Survival, 3. Good health, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Clinical Trials, Phase III as Topic, Doxorubicin, Antineoplastic Combined Chemotherapy Protocols, Feasibility Studies, Humans, Multicenter Studies as Topic, Prednisone, Female, Cyclophosphamide, Aged
Access URL: https://link.springer.com/content/pdf/10.1007/s00277-020-04345-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33242101
https://link.springer.com/content/pdf/10.1007/s00277-020-04345-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33242101/
http://www.ncbi.nlm.nih.gov/pubmed/33242101
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960591
https://link.springer.com/article/10.1007/s00277-020-04345-3
https://resolver.sub.uni-goettingen.de/purl?gro-2/83385
https://repository.publisso.de/resource/frl:6467030 -
14
Authors: et al.
Contributors: et al.
Source: The Lancet. 396:1090-1100
Subject Terms: Adult, Paclitaxel, Humanized / adverse effects, Antineoplastic Agents, Triple Negative Breast Neoplasms, Antibodies, Monoclonal, Humanized, Cyclophosphamide / administration & dosage, Antibodies, Albumins / administration & dosage, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Albumins, Monoclonal, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide / adverse effects, Humans, Paclitaxel / administration & dosage, Triple Negative Breast Neoplasms / drug therapy, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Cyclophosphamide, Antineoplastic Agents / adverse effects, Doxorubicin / administration & dosage, Middle Aged, Doxorubicin / adverse effects, Neoadjuvant Therapy, 3. Good health, [SDV] Life Sciences [q-bio], Antineoplastic Agents / administration & dosage, Doxorubicin, Humanized / administration & dosage, Female
Access URL: https://pubmed.ncbi.nlm.nih.gov/32966830
https://www.sciencedirect.com/science/article/pii/S014067362031953X
https://hal.archives-ouvertes.fr/hal-03046446
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31953-X/fulltext
https://ohsu.pure.elsevier.com/en/publications/neoadjuvant-atezolizumab-in-combination-with-sequential-nab-pacli
https://europepmc.org/article/MED/32966830
https://pubmed.ncbi.nlm.nih.gov/32966830/ -
15
Authors: et al.
Contributors: et al.
Source: British Journal of Haematology, 193, 1, pp. 52-62
British journal of haematology, Vol. 193, no. 1, p. 52-62 (2021)
British Journal of HaematologySubject Terms: GUIDELINES, THERAPY, Cyclophosphamide/administration & dosage, Congenital Abnormalities/epidemiology, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Agents, Immunological, 0302 clinical medicine, Lymphoma, Large B-Cell, Diffuse/complications, Pregnancy, Antineoplastic Combined Chemotherapy Protocols, Vincristine/administration & dosage, International Network on Cancer Infertility Pregnancy (INCIP), Antineoplastic Agents, Immunological/therapeutic use, Medical Oncology - Radboud University Medical Center, 1102 Cardiorespiratory Medicine and Haematology, Fetal Growth Retardation/chemically induced, Fetal Growth Retardation, Stillbirth/epidemiology, non-Hodgkin lymphoma, Incidence, Lymphoma, Non-Hodgkin, Pregnancy Outcome, WOMEN, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Stillbirth, Progression-Free Survival, 3. Good health, Vincristine, R-CHOP, Antibodies, Monoclonal, Murine-Derived/therapeutic use, Premature Birth, Female, pregnancy, Lymphoma, Large B-Cell, Diffuse, Rituximab, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Prednisolone/administration & dosage, Adult, Lymphoma, Non-Hodgkin/diagnosis, Adolescent, Prednisolone, Immunology, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, diffuse large B-cell lymphoma, Gestational Age, Pregnancy Outcome/epidemiology, Congenital Abnormalities, 03 medical and health sciences, Rituximab/therapeutic use, MANAGEMENT, Pregnancy Complications/chemically induced, Humans, Cyclophosphamide, Retrospective Studies, Science & Technology, Doxorubicin/administration & dosage, Infant, Newborn, maternal outcome, Pregnancy Complications, Infertility/chemically induced, Doxorubicin, Infertility, incidence, Premature Birth/chemically induced
Access URL: https://lirias.kuleuven.be/bitstream/123456789/660499/2/NHL_INCIP_manuscript_v2.docx
https://pubmed.ncbi.nlm.nih.gov/32945547
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232066
https://doi.org/10.1111/bjh.17103
https://pubmed.ncbi.nlm.nih.gov/32945547/
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-1227387
https://www.ncbi.nlm.nih.gov/pubmed/32945547
https://www.narcis.nl/publication/RecordID/oai%3Arepository.ubn.ru.nl%3A2066%2F232066
https://onlinelibrary.wiley.com/doi/10.1111/bjh.17103
https://pure.amsterdamumc.nl/en/publications/02dc75ee-cb28-4871-8978-0db625ba3938
https://doi.org/10.1111/bjh.17103
https://lirias.kuleuven.be/handle/123456789/660499
https://doi.org/10.1111/bjh.17103
https://hdl.handle.net/2066/232066
https://repository.ubn.ru.nl//bitstream/handle/2066/232066/232066.pdf
https://hdl.handle.net/2078.1/261615
https://biblio.vub.ac.be/vubir/(b10dd193-2eb1-4bf5-9bc7-369fe4b66f93).html -
16
Authors: et al.
Source: J Cancer Res Clin Oncol
Subject Terms: Adult, Male, Carcinoma, Hepatocellular, Original Article – Clinical Oncology, Severity of Illness Index, Carboplatin, Cohort Studies, 03 medical and health sciences, Ethiodized Oil, 0302 clinical medicine, Predictive Value of Tests, Germany, Humans, Chemoembolization, Therapeutic, Aged, Retrospective Studies, Aged, 80 and over, 2. Zero hunger, Carcinoma, Hepatocellular/mortality [MeSH], TACE, Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Ethiodized Oil/administration, Liver Neoplasms/therapy [MeSH], Chemoembolization, Therapeutic/methods [MeSH], Carcinoma, Hepatocellular/therapy [MeSH], Germany/epidemiology [MeSH], Cohort Studies [MeSH], Male [MeSH], Liver cancer, Doxorubicin/administration, Chemoembolization, Therapeutic/statistics, Carboplatin/administration, Female [MeSH], Liver Neoplasms/diagnosis [MeSH], Adult [MeSH], Humans [MeSH], Severity of Illness Index [MeSH], Treatment Outcome [MeSH], Carcinoma, Hepatocellular/diagnosis [MeSH], Predictive Value of Tests [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Stage migration, Survival Rate [MeSH], Liver Transplantation/statistics, Embolization, Liver Transplantation/methods [MeSH], Liver Neoplasms, Middle Aged, Liver Transplantation, 3. Good health, Survival Rate, Doxorubicin, Female
Access URL: https://link.springer.com/content/pdf/10.1007/s00432-020-03135-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32107625
https://link.springer.com/content/pdf/10.1007/s00432-020-03135-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32107625/
https://www.ncbi.nlm.nih.gov/pubmed/32107625
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085483
https://link.springer.com/article/10.1007/s00432-020-03135-8
https://www.mendeley.com/catalogue/4b887647-d3a7-3548-abf3-5b34db287b01/
https://repository.publisso.de/resource/frl:6467684 -
17
Authors: et al.
Contributors: et al.
Source: Journal of Clinical Oncology. 38:444-453
Subject Terms: Breast Neoplasms / drug therapy, Receptor, ErbB-2, Antineoplastic Agents, Breast Neoplasms, Docetaxel, Cyclophosphamide / administration & dosage, Fluorescence, Disease-Free Survival, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Immunological / administration & dosage, Chemotherapy, Humans, Trastuzumab / administration & dosage, Neoplasm Invasiveness, Cyclophosphamide, Adjuvant, In Situ Hybridization, In Situ Hybridization, Fluorescence, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Doxorubicin / administration & dosage, Middle Aged, Trastuzumab, ErbB-2 / biosynthesis, ErbB-2 / genetics, Immunohistochemistry, 3. Good health, Docetaxel / administration & dosage, Breast Neoplasms / genetics, Chemotherapy, Adjuvant, Doxorubicin, Breast Neoplasms / pathology, Female, Breast Neoplasms / enzymology, Receptor
Access URL: https://europepmc.org/articles/pmc7007289?pdf=render
https://pubmed.ncbi.nlm.nih.gov/31821109
https://ascopubs.org/doi/pdf/10.1200/JCO.19.01455
https://pubmed.ncbi.nlm.nih.gov/31821109/
https://ascopubs.org/doi/10.1200/JCO.19.01455
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31821109/
https://scholars.houstonmethodist.org/en/publications/nsabp-b-47nrg-oncology-phase-iii-randomized-trial-comparing-adjuv
https://scholars.houstonmethodist.org/en/publications/nsabp-b47nrg-oncology-phase-iii-randomized-trial-comparing-adjuvant-chemotherapy-with-or-without-trastuzumab-in-highrisk-invasive-breast-cancer-negative-for-her2-by-fish-and-with-ihc-1-or-2(bbc17b96-d858-489d-a4a1-4816df3a83b8).html -
18
Authors: et al.
Contributors: et al.
Subject Terms: Adolescent, Adult, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Cyclophosphamide/administration & dosage, Disease-Free Survival, Doxorubicin/administration & dosage, Female, Follow-Up Studies, HIV Infections/drug therapy, HIV Infections/immunology, HIV Infections/mortality, Humans, Lymphoma, Large B-Cell, Diffuse/drug therapy, Diffuse/immunology, Diffuse/mortality, Male, Middle Aged, Prednisone/administration & dosage, Survival Rate, Vincristine/administration & dosage, AIDS, HIV infection, diffuse large B-cell lymphoma
Relation: Hematological Oncology; https://iris.unil.ch/handle/iris/98392; serval:BIB_3E03D5BE9E1B; 000452625700005
-
19
Authors: et al.
Contributors: et al.
Subject Terms: Aged, Antibiotics, Antineoplastic/administration & dosage, Carcinoma, Hepatocellular/therapy, Chemoembolization, Therapeutic/methods, Doxorubicin/administration & dosage, Drug Carriers, Drug Implants, Female, Humans, Liver Neoplasms/therapy, Male, Prospective Studies, Single-Blind Method, Treatment Outcome
File Description: application/pdf
Relation: CardioVascular and Interventional Radiology; https://iris.unil.ch/handle/iris/95901; serval:BIB_14FF9F0AB2E9; 000274314600007
-
20
Authors: et al.
Subject Terms: Administration, Inhalation, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Appendiceal Neoplasms/drug therapy, Appendiceal Neoplasms/pathology, Carcinoma/drug therapy, Carcinoma/secondary, Cisplatin/administration & dosage, Colorectal Neoplasms/drug therapy, Colorectal Neoplasms/pathology, Doxorubicin/administration & dosage, Female, Gastrointestinal Neoplasms/drug therapy, Gastrointestinal Neoplasms/pathology, Humans, Injections, Intraperitoneal/methods, Male, Mesothelioma/drug therapy, Mitomycin/administration & dosage, Organoplatinum Compounds/administration & dosage, Ovarian Neoplasms/drug therapy, Ovarian Neoplasms/pathology, Peritoneal Neoplasms/drug therapy, Peritoneal Neoplasms/secondary, Practice Patterns, Physicians', Stomach Neoplasms/drug therapy, Stomach Neoplasms/pathology
File Description: application/pdf
Relation: European Journal of Surgical Oncology; https://iris.unil.ch/handle/iris/95188; serval:BIB_23BAA90FE322; 000437391100011
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text